AMWL AMWL
Company Profile ↓Company Overview
AMWL (AMWL) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 11.8% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $249.32M (-2.0% YoY); net profit $-95.70M.
- Trailing 12 Months Year-on-year growth — revenue -2.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 11.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 11.83% |
| 1 Year: | -1.98% |
Stock Price Performance
| 1 Year: | +84.94% |
| 6 Months: | +200.00% |
| 3 Months: | +104.72% |
| 1 Month: | +44.83% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)68.36 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 11.8% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 53.71M | 68.57M | 62.55M | 57.60M | 60.22M | 62.22M | 64.23M | 64.52M | 69.21M | 64.00M | 62.45M | 61.92M | 59.52M | 62.79M | 61.05M | 66.83M | 70.90M | 56.29M | 54.88M |
| Operating Income | -25.75M | -25.75M | -87.83M | -64.29M | -38.74M | -37.53M | -55.45M | -70.48M | -69.40M | -71.12M | -397.32M | -94.51M | -143.36M | -75.03M | -52.38M | -47.37M | -30.41M | -20.38M | -29.33M | -17.42M |
| Net Income | -24.02M | -24.38M | -86.66M | -63.08M | -39.19M | -37.86M | -51.49M | -70.04M | -69.14M | -70.08M | -397.69M | -92.47M | -136.41M | -72.11M | -49.92M | -43.46M | -18.70M | -19.70M | -32.38M | -10.89M |
| Diluted EPS | - | - | - | - | - | -0.15 | -0.20 | -0.26 | -0.25 | -0.25 | -1.42 | -6.53 | -9.54 | -4.94 | -3.36 | -2.87 | -1.19 | -1.24 | -2.00 | -0.66 |
| R&D Expense | 13.60M | 14.94M | 17.64M | 25.27M | 23.04M | 22.38M | 27.40M | 37.48M | 37.07M | 36.25M | 25.92M | 25.84M | 27.71M | 26.68M | 20.81M | 19.80M | 22.10M | 18.24M | 18.58M | 12.38M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 113.95M | 148.86M | 245.26M | 252.79M | 277.19M | 259.05M | 254.36M | 249.32M |
| Operating Income | -55.11M | -94.70M | -227.43M | -179.15M | -275.85M | -692.14M | -217.53M | -105.27M |
| Net Income | -52.67M | -87.19M | -224.43M | -176.33M | -270.43M | -675.16M | -208.14M | -95.70M |
| Diluted EPS | - | - | -2.27 | -0.69 | -19.72 | -47.50 | -13.88 | -5.96 |
| R&D Expense | 36.27M | 53.94M | 84.41M | 106.59M | 138.49M | 105.83M | 86.06M | 72.86M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 499.88M | 1.38B | 1.45B | 1.22B | 589.71M | 435.97M | 323.79M |
| Total Equity | -161.75M | -204.41M | -307.12M | 1.22B | 1.24B | 1.06B | 464.22M | 304.77M | 235.58M |
| Cash & Equivalents | - | 47.98M | 137.67M | 941.62M | 746.42M | 538.55M | 372.04M | 228.32M | 182.33M |
| Total Liabilities | - | - | 124.95M | 130.45M | 184.96M | 133.71M | 109.52M | 119.72M | 76.00M |
| Current Liabilities | - | - | 106.58M | 120.98M | 141.63M | 114.06M | 93.80M | 111.26M | 73.21M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -74.01M | -81.89M | -112.46M | - | -192.32M | -148.34M | -127.34M | -65.95M |
| Investing Cash Flow | -245.93M | 120.00M | -66.76M | - | -11.63M | -19.17M | -18.65M | 17.10M |
| Financing Cash Flow | 278.18M | 46.64M | 983.12M | - | -3.61M | 2.15M | 1.38M | 840.00K |
| Capital Expenditure | -1.91M | -1.34M | -3.32M | - | -10.45M | -15.25M | -15.22M | -21.00K |
| Free Cash Flow | -75.92M | -83.23M | -115.78M | - | -202.77M | -163.59M | -142.56M | -65.97M |
| Net Change in Cash | - | - | - | - | -207.56M | -165.36M | -144.61M | -48.01M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - |
| Operating Margin % | -48.4% | -63.6% | -92.7% | -70.9% | -99.5% | -267.2% | -85.5% | -42.2% |
| Net Margin % | -46.2% | -58.6% | -91.5% | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% |
| ROE % | 25.8% | 28.4% | -18.3% | -14.2% | -25.4% | -145.4% | -68.3% | -40.6% |
| ROCE % | - | -24.1% | -18.1% | -13.7% | -25.0% | -139.6% | -67.0% | -42.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMWL
Amwell raises 2026 revenue floor to $200M after Q2 report - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOVXZvLVEya2pfOFZSWmJ2aWtvcWxXUlBzNHJjSDlSTXhzYUpuTUdvZFQ0TTd6ZzRyT0Zqc2RZVDE2TFE4RzZOX2JzdnphcFZqb3E1bWFSOEU3ZHpkdi1ZeFNiNUhWSWNacGZGOVRNLVZwbGhWcWtBT1dMTTZyOV9lVzdick1hZTVycFd1d3…
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQQ3VuN3VBalNlWHBRVGRoSWh2RWVlYldTZHg1dlNZdjhSX1N3ZmNpVVJWV3ZtdjEwY21oYkJPQzNrYUhTZVgtRlRLQXFRdXAteFg2M2xmODdYZHBCYkktdW5NWUxYV0pWc2l6RVpIZXY1SWw2dURleEZKZVBIa2NVMGk3Mm1zNWN0bXJPQ1…
American Well Corporation Stock 12‑Month Price Target Raised to $11.58, Implies 11% Upside - TradingView
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxPa1ljT3dZckh5YXRua1E3bU5qQzA3dlhJdzdKeTZjV2RMUm5PaVU4MGpScFVpYlJCTEJMS1lLTk1HSWxFTjZycTZjREk4QWxkZktFMnhndTBRQk9GSktSb2RIRERQcWU5NjlqY0FBSXVEb2NicWhOd190SDVCZ0wxSnUybmZ2MVFCUHA0V0…
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNRXhCSmRkQzdmWGs1bnJkNjV4X3lLSkZBUDAwVVNKbU9RNFZnajlFbXowQXA1Sy1mN3NNcWlraVVFcnFSVkdSOEZBMVh2ZWdJUGFBMEMwS25CZ3psZDZDMWJkQUtwNHU5ZUFCa0duazQ3QVVDTHlJeUtSa25lQmdCSXgxNnBsSEdRZHhmVE…
Understanding the Setup: (AMWL) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNSFhCaVFzU1ZRZjc0X2JxcVUwM01vdzB6V1dfR1Z2cEhYZ2tfbEgtRzNQOXBMeEVXYkI4TXRDVkFXSlhNQkNMaXBwZXdlclgzX3F5dnI3OTBFNFUtYW9nWGwwbTMwTTRUc1lpa09ILVpyY05KZ0tHZzFCODVGdlpqdWIwLXlIYUZCazFXM2…
American Well Q2 2026 Earnings Call Transcript - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNelhzd0I1OUdkcERodEZTUm9oWHF0U1A4XzBMalFqZ2Z0TXNGQm5vTUt1VlhCNDk2UURTT3hmYkpGTElGWFd2RVB0MVU2QUlfc2FldGpIZ0FOVTE1cmFPRnc4NEtoRmhCM1pCVjN2NGx3OUhpQl82Sko4RmZCczFEYWVn?oc=5" target=…
AMWL — Frequently Asked Questions
What is the current share price of AMWL?
As of 2026-08-05 17:25 PDT, AMWL trades at $13.02 on NASDAQ/NYSE. Its 52-week range is $3.78 to $13.23.
What is the P/E ratio of AMWL?
AMWL trades at a trailing price-to-earnings (P/E) ratio of -2.18.
What is the return on equity (ROE) of AMWL?
AMWL has a return on equity (ROE) of -40.62%. Its return on capital employed (ROCE) is -42.01%.
Is AMWL a good stock to buy?
This page provides a data-driven analysis of AMWL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.